SCHEMBL13640246

SCHEMBL13640246

COc1c2[nH]c3ccc(Cl)cc3c2cc2c1[nH]c1ccc(Cl)cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB4A P04350 7/20 0.48
TUBB P07437 7/20 0.48
TUBA3C P0DPH7 7/20 0.48
TUBA1B P68363 7/20 0.48
TUBA4A P68366 7/20 0.48
TUBB4B P68371 7/20 0.48
TUBB3 Q13509 7/20 0.48
TUBB2A Q13885 7/20 0.48
TUBB8 Q3ZCM7 7/20 0.48
TUBA3E Q6PEY2 7/20 0.48
TUBA1A Q71U36 7/20 0.48
TUBA1C Q9BQE3 7/20 0.48
TUBB6 Q9BUF5 7/20 0.48
TUBB2B Q9BVA1 7/20 0.48
TUBB1 Q9H4B7 7/20 0.48
LMNA P02545 1/20 0.45
CHUK O15111 2/20 0.44
CYP1A2 P05177 1/20 0.44
GAA P10253 1/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17396502 0.81 MAP2 (0.47) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL1921071 0.81 KDM4E (0.47) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL1920387 0.80 KDM4E (0.41) LMNACHUKCYP1A2GAAHPGD
SCHEMBL1920226 0.79 KIF11 (0.47) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL1920490 0.79 AR (0.49) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL3209389 0.77 KDM4E (0.53) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL21086289 0.77 GRIN2D (0.49) LMNACHUKCYP1A2GAAHPGD
SCHEMBL3461668 0.76 RXFP1 (0.40) LMNACHUKCYP1A2GAAHPGD
SCHEMBL3460311 0.76 ADRA2A (0.49) CYP1A2GAAKDM4EMAPTRXFP1
SCHEMBL31612421 0.76 TUBB4A (0.51) TUBB4ATUBBTUBA3CTUBA1BTUBA4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2694057-B1 LIPOXYGENASE INHIBITORS STANFORD RES INST INT (US) 2019-06-05 EP disclosed
US-8399502-B2 Analogs of indole-3-carbinol and their use as agents against infection SRI INTERNATIONAL (US) 2013-03-19 US disclosed
US-20120283240-A1 Analogs of Indole-3-Carbinol and Their Use as Agents Against Infection SRI INTERNATIONAL 2012-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120283240-A1 Analogs of Indole-3-Carbinol and Their Use as Agents Against Infection IDO1, IDO2, TDO2 TUBB4A 1702/4885TUBB 632/4885TUBA3C 246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.